Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Quality of life among multiple sclerosis patients in Saudi Arabia

Hussein A. Algahtani, Bader H. Shirah, Faris A. Alzahrani, Hind A. Abobaker, Nebras A. Alghanaim and Juan S. Manlangit
Neurosciences Journal October 2017, 22 (4) 261-266; DOI: https://doi.org/10.17712/nsj.2017.4.20170273
Hussein A. Algahtani
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Bader H. Shirah
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faris A. Alzahrani
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hind A. Abobaker
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nebras A. Alghanaim
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan S. Manlangit
From the Neurology Section (Algahtani), Department of Medicine, King Abdulaziz Medical City, from King Abdullah International Medical Research Center (Shirah), King Saud bin Abdulaziz University for Health Sciences, and from King Saud bin Abdulaziz University for Health Sciences (Algahtani, Alzahrani, Abobaker, Alghanaim, Manlangit Jr), Jeddah, Kingdom of Saudi Arabia
Jr. MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Subjective assessment of EQ-5D dimensions instrument.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Frequency Distribution Histogram of EuroQOL-5 dimensions instrument index. EQ-5D- EuroQOL-5 dimensions

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Frequency Distribution Histogram of EuroQol Visual Analog Scale. EQ-VAS - EuroQol Visual Analog Scale

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Multiple sclerosis patients EQ-VAS mean scores by age group and gender.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    Correlation between EQ-5D index and EQ-VAS. EQ-5D- EuroQOL-5 Dimensions instrument

Tables

  • Figures
    • View popup
    Table 1

    Baseline demographics of multiple sclerosis patients.

    DemographicsWomenMenAll Patients
    Patients n (%)202 (69.2)90 (30.8)292
    Women vs Men--2.24:1 ratio
    Age (years)35.96 ±10.5935.94 ±9.5335.95±10.26)
    Age at disease onset28.33 ±9.6928.66 8.83±28.43±9.42
    Duration of illness (years)7.68±6.317.52 ±5.887.63±6.17
    Form of multiple sclerosis n (%)
    RRMS78 (26.7)181 (62)259 (88.7)
    SPMS6 (2.05)6 (2.05)12 (4.1)
    PPMS6 (2.05)15 (5.1)21(7.2)
    EQ-5D index0.27 (0.51)0.40 (0.50)0.31 (0.51)
    EQ-VAS73.24 (22.52)75.28 (25.38)73.87(23.41)
    • SD - standard deviation PRMS - Progressive-relapsing MS, SPMS - secondary progressive MS, PPMS - primary progressive MS, EQ-5D - EuroQOL-5 Dimensions instrument

    • View popup
    Table 2

    Frequency distribution of MS patients reporting levels 1 to 5 by dimensions and by age group.

    EQ-5D dimensionsAge groupTotal
    14-2021-3031-4041-5051-6061-70
    Mobility level
      182325149079
      20925191155
      311519132353
      4061582031
      522924125274
    Self-Care level
      18314323101116
      2041390026
      307971024
      4021096229
      533833182397
    Usual Activity level
      162538149193
      201116190046
      31923103147
      431710134249
      512021103257
    Pain/Discomfort level
      151935176082
      231724126264
      301116182350
      412014145054
      52151950142
    Anxiety/Depression level
      161828213177
      211223114152
      311821135260
      432112145156
      50132472147
    • MS - multiple sclerosis, EQ-5D- EuroQOL-5 Dimensions instrument

    • View popup
    Table 3

    Multiple linear regression analysis of association between demographic and illness information variables to EQ-5D index value score.

    Independent VariablesDependent variable (EQ-5D index score)
    Unstandardized
    coefficients B
    Standardized
    coefficients B
    P-value
    Age.005.090.170
    Gender-.121-.109.064
    Duration of Illness in years-.009-.105.107
    On treatment and not on treatment.044.032.588
    • B - Beta, EQ-5D - EuroQOL-5 Dimensions instrument

PreviousNext
Back to top

In this issue

Neurosciences Journal: 22 (4)
Neurosciences Journal
Vol. 22, Issue 4
1 Oct 2017
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quality of life among multiple sclerosis patients in Saudi Arabia
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Quality of life among multiple sclerosis patients in Saudi Arabia
Hussein A. Algahtani, Bader H. Shirah, Faris A. Alzahrani, Hind A. Abobaker, Nebras A. Alghanaim, Juan S. Manlangit
Neurosciences Journal Oct 2017, 22 (4) 261-266; DOI: 10.17712/nsj.2017.4.20170273

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quality of life among multiple sclerosis patients in Saudi Arabia
Hussein A. Algahtani, Bader H. Shirah, Faris A. Alzahrani, Hind A. Abobaker, Nebras A. Alghanaim, Juan S. Manlangit
Neurosciences Journal Oct 2017, 22 (4) 261-266; DOI: 10.17712/nsj.2017.4.20170273
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Exploring physiotherapist’s ability to identify cauda equina syndrome early
  • Does the severity of facet joint osteoarthritis affect facet medial branch radiofrequency thermocoagulation results?
  • Thunderclap headache management among Emergency Department visitors in tertiary care center in Makkah City: Retrospective cohort study
Show more Original Article

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire